Skip to main content

Together we are beating cancer

Donate now

Liquid-based cytology

Showing 3 out of 3 results

Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England. Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England.

by Cancer Research UK | News | 14 June 2013

14 June 2013

Cancer Research UK logo

Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool. Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool.

by The National Cancer Research Institute (NCRI) | News | 10 November 2010

10 November 2010

Cancer Research UK logo

Today, at the Britain Against Cancer conference, the NHS Cervical Screening Programme announces the introduction of liquid based cytology (LBC) and a change in national policy. Today, at the Britain Against Cancer conference, the NHS Cervical Screening Programme announces the introduction of liquid based cytology (LBC) and a change in national policy.

by Cancer Research UK | News | 22 October 2003

22 October 2003